Clinical Trial

A Study of MSK-TCR5 in People With Solid Tumor Cancers

Name: A Study of MSK-TCR5 in People With Solid Tumor Cancers — clinical trial record (NCT07638371)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to test the safety of MSK-TCR5 in participants with advance solid tumor cancer that has a KRAS, HRAS, or NRAS G12D mutation.

Trial Details

NCT Number	NCT07638371
Lead Sponsor	Memorial Sloan Kettering Cancer Center
Conditions	Solid Tumor, Solid Carcinoma, Advanced Solid Tumor, Unresectable Solid Tumor, Metastatic Solid Tumor
Enrollment	16 participants
Start Date	2026-06-09
Primary Completion	2030-06-09 (estimated)
Study Completion	2030-06-09 (estimated)
Updated on ClinicalTrials.gov	2026-06-11